Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott G Franzblau

Showing results (1-10 of 246) with videos related to

Pageof 25
Sort By:
Antimicrobial Agents and Chemotherapy|November 26, 2003
Improved green fluorescent protein reporter gene-based microplate screening for antituberculosis compounds by utilizing an acetamidase promoterChartchai Changsen, Scott G Franzblau, Prasit Palittapongarnpim
Translational Research : the Journal of Laboratory and Clinical Medicine|April 11, 2020
New tuberculosis drug targets, their inhibitors, and potential therapeutic impactGauri S Shetye, Scott G Franzblau, Sanghyun Cho
European Journal of Medicinal Chemistry|June 7, 2011
Design, synthesis and anti-tubercular evaluation of new 2-acylated and 2-alkylated amino-5-(4-(benzyloxy)phenyl)thiophene-3-carboxylic acid derivatives. Part 1Xiaoyun Lu, Baojie Wan, Scott G Franzblau, et al.
Heterocycles|October 18, 2011
UTILIZTION OF THE SUZUKI COUPLING TO ENHANCE THE ANTITUBERCULOSIS ACTIVITY OF ARYL OXAZOLESGarrett C Moraski, Scott G Franzblau, Marvin J Miller
Plos One|September 24, 2015
glpx Gene in Mycobacterium tuberculosis Is Required for In Vitro Gluconeogenic Growth and In Vivo SurvivalHiten J Gutka, Yuehong Wang, Scott G Franzblau, et al.
Organic & Biomolecular Chemistry|August 17, 2012
Syntheses of mycobactin analogs as potent and selective inhibitors of Mycobacterium tuberculosisRaúl E Juárez-Hernández, Scott G Franzblau, Marvin J Miller
Bioorganic & Medicinal Chemistry Letters|September 27, 2008
Synthesis and in vitro biological evaluation of ring B abeo-sterols as novel inhibitors of Mycobacterium tuberculosisXiaomei Wei, Abimael D Rodríguez, Yuehong Wang, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|June 4, 2011
Crystallization and preliminary X-ray characterization of the glpX-encoded class II fructose-1,6-bisphosphatase from Mycobacterium tuberculosisHiten J Gutka, Scott G Franzblau, Farahnaz Movahedzadeh, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|January 12, 2013
Current prospects of synthetic curcumin analogs and chalcone derivatives against mycobacterium tuberculosisSyed Nasir Abbas Bukhari, Scott G Franzblau, Ibrahim Jantan, et al.
Chemistry & Biodiversity|December 29, 2006
Antituberculotic and antiprotozoal activities of primin, a natural benzoquinone: in vitro and in vivo studiesDeniz Tasdemir, Reto Brun, Vanessa Yardley, et al.
Pageof 25

Showing results (1-10 of 246) with videos related to

Sort By:
Pageof 25
Antimicrobial Agents and Chemotherapy|November 26, 2003
Improved green fluorescent protein reporter gene-based microplate screening for antituberculosis compounds by utilizing an acetamidase promoterChartchai Changsen, Scott G Franzblau, Prasit Palittapongarnpim
Translational Research : the Journal of Laboratory and Clinical Medicine|April 11, 2020
New tuberculosis drug targets, their inhibitors, and potential therapeutic impactGauri S Shetye, Scott G Franzblau, Sanghyun Cho
European Journal of Medicinal Chemistry|June 7, 2011
Design, synthesis and anti-tubercular evaluation of new 2-acylated and 2-alkylated amino-5-(4-(benzyloxy)phenyl)thiophene-3-carboxylic acid derivatives. Part 1Xiaoyun Lu, Baojie Wan, Scott G Franzblau, et al.
Heterocycles|October 18, 2011
UTILIZTION OF THE SUZUKI COUPLING TO ENHANCE THE ANTITUBERCULOSIS ACTIVITY OF ARYL OXAZOLESGarrett C Moraski, Scott G Franzblau, Marvin J Miller
Plos One|September 24, 2015
glpx Gene in Mycobacterium tuberculosis Is Required for In Vitro Gluconeogenic Growth and In Vivo SurvivalHiten J Gutka, Yuehong Wang, Scott G Franzblau, et al.
Organic & Biomolecular Chemistry|August 17, 2012
Syntheses of mycobactin analogs as potent and selective inhibitors of Mycobacterium tuberculosisRaúl E Juárez-Hernández, Scott G Franzblau, Marvin J Miller
Bioorganic & Medicinal Chemistry Letters|September 27, 2008
Synthesis and in vitro biological evaluation of ring B abeo-sterols as novel inhibitors of Mycobacterium tuberculosisXiaomei Wei, Abimael D Rodríguez, Yuehong Wang, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|June 4, 2011
Crystallization and preliminary X-ray characterization of the glpX-encoded class II fructose-1,6-bisphosphatase from Mycobacterium tuberculosisHiten J Gutka, Scott G Franzblau, Farahnaz Movahedzadeh, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|January 12, 2013
Current prospects of synthetic curcumin analogs and chalcone derivatives against mycobacterium tuberculosisSyed Nasir Abbas Bukhari, Scott G Franzblau, Ibrahim Jantan, et al.
Chemistry & Biodiversity|December 29, 2006
Antituberculotic and antiprotozoal activities of primin, a natural benzoquinone: in vitro and in vivo studiesDeniz Tasdemir, Reto Brun, Vanessa Yardley, et al.
Pageof 25